All treatments
Treatment
Bemnifosbuvir Hemisulfate clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic exploratory (Phase II)
A Phase 2, Open-Label Study to Assess the Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects with Chronic Hepatitis C Virus (HCV) Infection
This study is testing two new medicines, bemnifosbuvir and ruzasvir, to see how well and how safely they treat chronic Hepatitis C infection. We want to find out if these medicines can clear the virus from people's bodies.
For: Chronic Hepatitis C Virus (HCV) InfectionRomania · Germany · Spain - Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients with COVID-19
This study is testing new treatments for COVID-19 in people who are at higher risk of becoming very unwell. It compares a new medicine called Bemnifosbuvir with usual care and Paxlovid to see if it helps prevent serious illness or hospital stays.
For: COVID-19Latvia · Netherlands · Sweden